EFDID: 75486EFD: View Filing

Issuer: Genesis Biopharma, Inc (0001425205) - D

Accession: 0001513160-13-000035 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001425205
  • Entity Name:
    Genesis Biopharma, Inc
  • Entity Type:
    Corporation
  • Jurisdiction:
    NEVADA
  • Year of Inc:
    Over 5 years ago
  • Address:
    10960 Wilshire Boulevard
    Suite 1050
    Los Angeles, CA 90024
  • Persons:
    Related Persons 4
    Michael Handelman
    Executive Officer
    Paul Kessler
    Director
    David Voyticky
    Director
    Merrill McPeak
    Executive OfficerDirector
EDGAR: Offering Information
  • Accession Date:
    06/06/2013
  • First Sale Date:
    05/22/2013
  • Offering Amount:
    $1,350,000
  • Amount Sold:
    $1,350,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    $1,350,000 in cash, other consideration in the cancellation of $9,267,640 in debt and the exchange of 12,273,418 warrants.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Genesis Biopharma, Inc/s/ Michael HandelmanMichael HandelmanChief Financial Officer2013-06-06